REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults
Completed · Not applicable
Conditions studied: Type 2 Diabetes (Adult Onset), Medication Adherence
In brief
Latino individuals, the fastest growing ethnic minority population in the United States, have a higher prevalence of type 2 diabetes and diabetes-related complications, and are more likely to report inconsistent use of diabetes medications than non-Hispanic White individuals. The proposed project will test an interactive text message-based tool tailored to address barriers to taking diabetes medications that are relevant to Latino adults. If found feasible, acceptable, and usable, this intervention could serve as a scalable tool to improve diabetes management and reduce diabetes-related complications among Latino adults in the United States.
Key facts
- Study ID
- NCT06000813
- Run by
- Massachusetts General Hospital
- People needed
- 70
- Starts
- 2024-06-18
- Expected to finish
- 2026-05-27
- Last updated by the study team
- 2026-06-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Type 2 diabetes mellitus
- Have current or prior (since 2018) HbA1c ≥8.0%
- Take at least one diabetes medication
- Receive care at MGH- affiliated primary care practices (≥2 visits in the past 3 years)
- ≥18 yrs
- Identify as Latino and/or Hispanic
- Speak and read in Spanish as preferred language
- Willing and able to provide informed consent
- Access to a mobile telephone with text messaging capability
- Suboptimal diabetes medication adherence, assessed using the first 2 items in the Adherence to Refill and Medication Scale (ARMS-d) questionnaire combined: "How frequently do you forget or decide to not take your diabetes medications?" Participants who answer sometimes, almost always, and/or always will be considered eligible for the study.
You may not qualify if…
- Auditory limitations and/or inability to communicate orally
- Inability to receive, read, or send a text message (assessed by a trained research assistant)
Where it is running
- Massachusetts General Hospital Diabetes Research Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.